Assessing vitamin D in the central nervous system

Acta Neurologica Scandinavica

Volumn 122, Issue SUPPL. 190, 2010, Pages 88-92

  Holmoy T ^a,b   Moen, S M ^a,b  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

Cerebrospinal fluid; Multiple sclerosis; Vitamin D

Indexed keywords

VITAMIN D;

ALZHEIMER DISEASE; BRAIN DEVELOPMENT; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CLINICAL ASSESSMENT; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; REVIEW; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 77953202999     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2010.01383.x     Document Type: Review

References (49)

1. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006;116 : 2062-2072.
2. Haagensen CD, Lloyd WEB. A hundred years of medicine. Washington DC: Sheridan House, 1943. reprinted in 2000 by Beard Books.
3. Hess AF. On the induction of antirachitic prperties in rations by exposure to sunlight. Science 1924;60 : 269.
4. Hume EM, Smith HH. The effect of irradiation of the environment with ultra-violet light upon the growth and calcification of rats, fed on a diet deficient in fat-soluble vitamins. The Part played by irradiated sawdust. Biochem J 1924;18 : 1334-1348.
5. Steenbock H. The induction of growth promoting and calcifying properties in a ration by exposure to light. Science 1924;60 : 224-225.
6. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009;19 : 73-8.
7. Mørner KAH. The Nobel Prize in Physiology or Medicine, 1903. Presentation Speech. http://nobelprize.org/nobel-prizes/medicine/laureates/1903/ press.html.
8. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med 2010 Epub Feb 1 2010, PMID: 20119827.
9. Tsoukas CD, Provvedini DM, Manolagas SC. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 1984;224 : 1438-1440.
10. Tuohimaa P, Keisala T, Minasyan A, Cachat J, Kalueff A. Vitamin D, nervous system and aging. Psychoneuroendocrinology 2009;34 (Suppl. 1) 278-286.
11. Neveu I, Naveilhan P, Menaa C, Wion D, Brachet P, Garabeidan M. Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro. J Neurosci Res 1994;38 : 214-220.
12. Eyles DW, Smith S, Kinobe R, Hewison M, Mcgrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005;29 : 21-30.
13. Monakawa T, Hayashi M, Saruta T. Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages. Kidney Int 2000;58 : 559-568.
14. Bouillon R, Carmeliet G, Verlinden L et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008;29 : 726-776.
15. Wang TT, Tavera-Mendoza LE, Laperriere D et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol 2005;19 : 2685-2695.
16. Khanal RC, Peters TM, Smith NM, Nemere I. Membrane receptor-initiated signaling in 1,25(OH)2D3-stimulated calcium uptake in intestinal epithelial cells. J Cell Biochem 2008;105 : 1109-1116.
17. Stumpf WE, Sar M, Clark SA, Deluca HF. Brain target sites for 1,25-dihydroxyvitamin D3. Science 1982;215 : 1403-1405.
18. Naveilhan P, Neveu I, Wion D, Brachet P. 1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 1996;7 : 2171-2175.
19. Wion D, Macgrogan D, Neveu I, Jehan F, Hougatte R, Brachet P. 1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J Neurosci Res 1991;28 : 110-114.
20. Taniura H, Ito M, Sanada N et al. Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons. J Neurosci Res 2006;83 : 1179-1189.
21. Marini F, Bartoccini E, Cascianelli G et al. Effect of 1alpha,25-dihydroxyvitamin D3 in embryonic hippocampal cells. Hippocampus 2009 Epub Feb 14 2009, PMID: 19603526.
22. Eyles DW, Feron F, Cui X et al. Developmental vitamin D deficiency causes abnormal brain development. Psychoneuroendocrinology 2009;34 (Suppl.1): 247-257.
23. Feron F, Burne TH, Brown J et al. Developmental vitamin D3 deficiency alters the adult rat brain. Brain Res Bull 2005;65 : 141-148.
24. Myhr KM. Vitamin D treatment in multiple sclerosis. J Neurol Sci 2009;286 : 104-108.
25. Goldberg P, Fleming MC, Picard EH. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 1986;21 : 193-200.
26. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296 : 2832-2838.
27. Munger KL, Zhang SM, O'relly E et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62 : 60-5.
28. Salzer J, Svenningsson A, Sundstrøm P. Season of birth and multiple sclerosis in Sweden. Acta Neurol Scand 2010;121 : 20-3.
29. Kampman MT, Brustad M. Vitamin D: a candidate for the environmental effect in multiple sclerosis - observations from Norway. Neuroepidemiology 2008;30 : 140-146.
30. Correale J, Yssraelit MC, Gaitan MI. Immunomodulatory effects of vitamin D in multiple sclerosis. Brain 2009;132 : 1146-1160.
31. Smolders J, Thewissen M, Peelen E et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS ONE 2009;4 : e6635.
32. Ramagopalan SV, Maugeri NJ, Handunnetthi L et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet 2009;5 : e1000369.
33. Mahon BD, Gordon SA, Cruz J, Cosman F, Cantorna MT. Cytokine profile in patients with multiple sclerosis following vitamin D supplementation. J Neuroimmunol 2003;134 : 128-132.
34. Nashold FE, Spach KM, Spanier JA, Hayes CE. Estrogen controls vitamin D3-mediated resistance to experimental autoimmune encephalomyelitis by controlling vitamin D3 metabolism and receptor expression. J Immunol 2009;183 : 3672-3681.
35. Celius EG, Smestad C. Change in sex ratio, disease course and age at diagnosis in Oslo MS patients through seven decades. Acta Neurol Scand Suppl 2009;189 : 27-9.
36. Baas D, Prufer K, Ittel ME et al. Rat oligodendrocytes express the vitamin D(3) receptor and respond to 1,25-dihydroxyvitamin D(3). Glia 2000;31 : 59-68.
37. de Apreu DA, Eyles D, Feron F. Vitamin D, a neuro-immunomodulator: implications for neurodegenerative and autoimmune diseases. Psychoneuroendocrinology 2009;34 (Suppl. 1): 265-277.
38. Cass WA, Smith MP, Peters LE. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine. Ann NY Acad Sci 2006;1074 : 261-271.
39. Kalueff AV, Minasyan A, Keisala T, Kuuslathi M, Miettinen S, Tuohimaa P. Increased severity of chemically induced seizures in mice with partially deleted Vitamin D receptor gene. Neurosci Lett 2006;394 : 69-73.
40. Spector R, Johanson CE. Vitamin transport and homeostasis in mammalian brain: focus on Vitamins B and E. J Neurochem 2007;103 : 425-438.
41. Xiao F, Chen D, Lu Y et al. Proteomic analysis of cerebrospinal fluid from patients with idiopathic temporal lobe epilepsy. Brain Res 2009;1255 : 180-189.
42. Qin Z, Qin Y, Liu S. Alteration of DBP levels in CSF of patients with MS by proteomics analysis. Cell Mol Neurobiol 2009;29 : 203-210.
43. Ottervald J, Franzen B, Nilsson K et al. Multiple sclerosis: Identification and clinical evaluation of novel CSF biomarkers. J Proteomics 2010;73 : 1117-1132.
44. Gascon-Barre M, Huet PM. Apparent [3H]1,25-dihydroxyvitamin D3 uptake by canine and rodent brain. Am J Physiol 1983;244 : 266-271.
45. Pardridge WM, Sakiyama R, Coty WA. Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier. J Neurochem 1985;44 : 1138-1141.
46. Balabanova S, Richter HP, Antoniadis G et al. 25-Hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human cerebrospinal fluid. Klin Wochenschr 1984;62 : 1086-1090.
47. Holmøy T, Moen SM, Gundersen TA et al. 25-hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis. Mult Scler 2009;15 : 1280-1285.
48. Kremer R, Herscovitch P, Goltzman D. Detection of 25-hydroxyvitamin D in human cerebrospinal fluid. Clin Res 1980;28 : 692 Abstract).
49. Torkildsen Ø, Knappskog PM, Nyland HI, Myhr KM. Vitamin D-dependent rickets as a possible risk factor for multiple sclerosis. Arch Neurol 2008;65 : 809-811.